About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Ganglioside and IBD | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04782544

Ganglioside and IBD

Context. Inflammatory bowel disease (IBD) is a chronic and debilitating disorder. Novel treatment strategies aimed to resolve intestinal inflammation and induce disease remission are necessary. Dietar...

Lead sponsor: Children's Hospital of Orange County•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Children's Hospital of Orange County

Age

9 - 21 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Participants age 9-21 years
•2. Mild-moderate IBD defined by ImproveCareNow (ICN) Physician Global Assessment (PGA); OR severe IBD defined by ICN PGA if stable for at least 120 days
•3. Ileal, ileocolonic, colonic location of disease

Exclusion Criteria

•1. Pregnancy
•2. Previous bowel resection
•3. Non-ileocolonic location of disease
•4. Inadequate liver or renal function
•5. On prescription medication for active infectious disease
•6. Drug/alcohol abuse
•7. Other serious medical conditions

Related studies

RECRUITINGPhase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease

RECRUITINGPhase 2/3

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

NCT05986136 · Inflammatory Bowel Diseases

Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease

NCT06266663 · Inflammatory Bowel Diseases

Predicting IBD Treatment Outcomes With Gut Microbiome Analysis

NCT06453720 · Inflammatory Bowel Diseases, Crohn Disease

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 13, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment11

Start dateJun 2021

Last updatedMar 13, 2025

Condition

Inflammatory Bowel Diseases

Locations shown

Children's Hospital of Orange County

Orange, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions